Khushbu Shah

10 Years Of Biosimilars: Lessons And Trends

Cellular Pharmacodynamics Of A Novel Pyrrolo [3, 2-d] Pyrimidine Inhibitor Targeting Mitochondrial And Cytosolic One-Carbon Metabolism

Development Of Substituted Pyrido[3,2-D]Pyrimidines As Potent And Selective Dihydrofolate Reductase Inhibitors For Pneumocystis Pneumonia Infection

Novel Pyrrolo[3,2-D]Pyrimidine Compounds Target Mitochondrial And Cytosolic One-Carbon Metabolism With Broad-Spectrum Antitumor Efficacy